Clinical Neuroimmunology

2. Auflage 2005
ISBN: 978-0-19-851068-0
Verlag: Oxford University Press

Buch, Englisch, 466 Seiten, Format (B × H): 222 mm x 284 mm, Gewicht: 1531 g

Clinical Neurimmunology is the major reference text in the field, providing broad and comprehensive coverage of the interaction between the nervous and immune systems in both normal and diseased states. Understanding this interaction is fundamental to developing therapeutic approaches to disease and injury of the nervous system that are currently only marginally amenable to therapy. Neuroimmunology is a well-recognised and growing specialty world wide, both at the basic science and clinical level. It is a fast moving field and this is the most up to date text available. Chapters are dedicated to the role of the immune system in disorders affecting both the central and peripheral nervous systems, including important neurodegenerative diseases (such as multiple sclerosis and HIV-related neural degeneration) which cause life-long disability. Extensive coverage is given to a whole array of immune-directed therapies.

The book has a strong international team of well respected, high profile editors and authors. The first edition published to extensive and positive reviews and has established itself as the principal reference source in the field. This second edition summarizes recent advances in clinical neuroimmunology in a comprehensive and unbiased way.

Zielgruppe

Clinical neurologists, immunologists, researchers in neuroimmunology and neuroscientists

Autoren/Hrsg.

Antel, Jack

Birnbaum, Gary

Hartung, Hans-Peter

Vincent, Angela

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft

Inhaltsverzeichnis

- 1: Byron Waksman: A brief history of neuroimmunology

- 2: Jack Antel, Gary Birnbaum and Hans-Peter Hartung: Basics of immunology

- 3: Jack Antel, Gary Birnbaum and Hans-Peter Hartung: Assessing immune function in clinical neuroimmunologic disease

- 4: David Hafler: Principles of autoimmunity

- 5: Reinhold Hohfield, Bernard Hemmer and Hans-Peter Hartung: Principles of immunotherapy

- 5b: Matthew Wood: Organisation and development of the central nervous system

- 6: Burkhard Becher: Immunology properties of the CNS

- 7: Sam David and Steve Lacroix: Role of the immune response in neuroprotection and repair

- 8: Hans-Peter Hartung: Immunology properties of the PNS

- 9: Steven Hauser, Jorge Oksenberg and David Brassat: Genetics of immune-mediated neurologic diseases

- 10: Pierre Talbot: Principles of immune-virus interactions in the nervous system

- 11: Walter Pfister and Uwe Koedel: Immunity of bacterial infections

- 12: Trevor Owens and Iain Campbell: Animal models of neuroimmunologic disease

- 13: Robert Lisak and Alex Tselis: Acute disseminated encephalomyelitis

- 14: Bruce Trapp and Richard Ransohoff: Multiple Sclerosis - immunopathology

- 15: Ken Smith and Richard Evans: Multiple Sclerosis - effects of immune mediators on neurophysiologic function

- 16: Doug Arnold, Nicola de Stefano, Zografos Caramanos, Roger Gunn and Joseph Frank: Multiple Sclerosis - monitoring the immuno-biology by neuroimaging

- 17: Jack Antel and Gary Birnbaum: Clinical immunology

- 18: Hans-Peter Hartung, Bernard Hemmer and Bernd Kieseier: Multiple Sclerosis - immune-directed therapy

- 19: Hans-Peter Hartung, Bernard Hemmer and Bernd Kieseier: Acute Inflammatory Neuropathies

- 20: John Pollard: Chronic inflammatory neuropathies

- 21: Angela Vincent: Antibody mediated disorders of the neuromuscular junction

- 22: Marinos Dalakas: Inflammatory diseases of muscle

- 23: Chris Power and Guido van Marle: HIV infection and the nervous system

- 24: Steve Jacobson, Utano Tomaru and Yoshihisa Yamano: HTLV-1 infection and the nervous system

- 25: Andrew Pachner: Lyme disease

- 26: Josep Dalmau: Paraneoplastic syndromes

- 27: Norman Latov, Andreas Steck and Susanne Renaud: Paraproteinemic neuropathies

- 28: Aksel Siva, Ayse Altintas and Sabahattin Saip: Bechet's disease

- 29: Patrick McGeer and Edith McGeer: Role of neural-immune interactions in neurodegenerative diseases

- 30: Nicolas de Tribolet: CNS neoplastic diseases and the immune system

- 31: Paula Dore-Duffy and Rouman Balabanov: Vasculitis disorders of the nervous system

- 32: Esther Sternberg: Psycho-neuro immunology

- 33: Boris Zalc and Catherine Lubetzki: Regeneration of the CNS

- 34: Guido Stoll and John Hallenbeck: Immunological aspects of cerebal ischemia

- 35: Angela Vincent: Antibodies and CNS disorders

- 36: Jack Antel, Gary Birnbaum and Hans-Peter Hartung: Immunologic dictionary

Über Autor(innen)

Edited by Jack Antel, Professor, Depratment of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada, Gary Birnbaum, Minneapolis Clinic of Neurology, Mineapolis, USA, Hans-Peter Hartung, Department of Neurology, Heinrich-Heine University, Dusseldorf, Germany, and Angela Vincent, Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK

Contributors: Ayse Altintas, Istanbul University, Cerrahpasa School of Medicine,Turkey Jack Antel, Montreal Neurological Institute, Canada Doug Arnold, Montreal Neurological Institute, Canada Rouman Balabanov, Department of Neurology, University of Chicago Hospitals, USA Burkhard Becher, Dartmouth Medical Center, Lebanon, New Hampshire, USA Gary Birnbaum, Minneapolis Clinic of Neurology, Minnesota, USA David Brassat, University of California, San Francisco, USA Iain Campbell, Department of Neuropharmacology, The Scripps Research Institute, California, USA Zografos Caramanos, Magnetic Resonance Spectroscopy Unit and Neurological Institute, Montreal, Canada Marinos Dalakas, Neuromuscular Diseases Division, National Institute of Neurological Disorders, Bethesda, USA Josep Dalmau, University of Arkansas for Medical Sciences, Little Rock, USA Sam David, Centre for Research in Neuroscience, Montreal General Hospital, Canada Paula Dore-Duffy, Department of Neurology, Wayne State University, Detroit, USA Richard Evans, Department of Neuroimmunology, GKT School of Medicine, London, UK Joseph Frank, Experimental Neuroimaging Section, NIH, Bethesda, USA Roger Gunn, Montreal Neurological Institute, Canada David Hafler, Brigham and Women's Hospital, Boston, USA Hans-Peter Hartung, Heinrich-Heine University, Dusseldorf, Germany Steven Hauser, University of California, San Francisco, USA Bernard Hemmer, Klinikum der Philipps-Universitat, Marburg, Germany Reinhold Hohfield, Institute for Clinical Neuroimmunology, Unversity of Munich, Germany Steve Jacobson, Viral Immunology Section, National Institute of Neurological Disorders, Bethesda, USA Bernd Kieseier, Department of Neurology, University of Dusseldorf, Germany Uwe Koedel, Neurologic Klinik and Institute for Clinical Neuroimmunology, Munich, Germany Steve Lacroix, Research Center, House CHUL, Laval University, Quebec, Canada Norman Latov, Weill Medical College, Cornell University, New York, USA Robert Lisak, Department of Neurology, Wayne State University, Detroit, USA Catherine Lubetzki, Biologie des Interactions Neurone/Glie, Hopital de la Salpetriere, Paris, France Guido van Marle, University of Calgary, Canada Edith McGeer, UBC Department of Psychiatry, Vancouver, Canada Patrick McGeer, UBC Department of Pstchiatry, Vancouver, Canada Jorge Oksenberg, University of California, San Francisco, USA Trevor Owens, Montreal Neurological Institute, Canada Andrew Pachner, Princeton, USA Walter Pfister, Neurologic Klinik and Institute for Clinical Neuroimmunology, Munich, Germany John Pollard, Hospital of the University of Pennsylvania, Philadelphia, USA Chris Power, Department of Clinical Neuroscience, University of Calgary, Canada Richard Ransohoff, Department of Neurosciences, Lerner Research Institute, Cleveland, USA Susanne Renaud, Weill Medical College, Cornell, New York, USA Sabahattin Saip, Istanbul University, Cerrahpasa School of Medicine, Turkey Aksel Siva, Istanbul University, Cerrahpasa School of Medicine, Turkey Ken Smith, Department of Neuroimmunology, GKT School of Medicine, London, UK Andreas Steck, Department of Neurology, University Clinics, Kantonsspital, Basel, Switzerland Nicola de Stefano, NMR Centre and Neurometabolic Unit, University of Siena, Italy Esther Sternberg, Neuroendocrine/Immunology, National Institute of Neurological Disorders, Bethesda, USA Pierre Talbot, INRS - Institut Armand-Frappier, Laval, Canada Utano Tomaru, Deaprtment of Pathology, Hokkaido University, Medical School, Japan Bruce Trapp, Department of Neurosciences, Cleveland, USA Nicolas de Tribolet, Service d